Skip to main content

1 Result(s)

within Christine C Tomlinson Remove this filter

and

  1. Article

    Open Access

    Cross-species genomic and functional analyses identify a combination therapy using a CHK1 inhibitor and a ribonucleotide reductase inhibitor to treat triple-negative breast cancer

    Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer that is diagnosed in approximately 15% of all human breast cancer (BrCa) patients. Currently, no targeted therapies exist for this...

    Christina N Bennett, Christine C Tomlinson… in Breast Cancer Research (2012)

    Download PDF (3618 KB) View Article